Year |
Citation |
Score |
2016 |
Li ZZ, Bai L, Wang F, Zhang ZC, Wang F, Zeng ZL, Zeng JB, Zhang DS, Wang FH, Wang ZQ, Li YH, Shao JY, Xu RH. Comparison of KRAS mutation status between primary tumor and metastasis in Chinese colorectal cancer patients. Medical Oncology (Northwood, London, England). 33: 71. PMID 27270901 DOI: 10.1007/s12032-016-0787-z |
0.361 |
|
2016 |
Li ZZ, Wang F, Zhang ZC, Wang F, Zhao Q, Zhang DS, Wang FH, Wang ZQ, Luo HY, He MM, Wang DS, Jin Y, Ren C, Qiu MZ, Ren J, ... ... Xu RH, et al. Mutation profiling in chinese patients with metastatic colorectal cancer and its correlation with clinicopathological features and anti-EGFR treatment response. Oncotarget. PMID 27050078 DOI: 10.18632/oncotarget.8541 |
0.365 |
|
2014 |
Qiu M, Zhou Y, Zhang X, Wang Z, Wang F, Shao J, Lu J, Jin Y, Wei X, Zhang D, Wang F, Li Y, Yang D, Xu R. Lauren classification combined with HER2 status is a better prognostic factor in Chinese gastric cancer patients. Bmc Cancer. 14: 823. PMID 25380654 DOI: 10.1186/1471-2407-14-823 |
0.335 |
|
2011 |
Li YH, Wang F, Shen L, Deng YM, Shao Q, Feng F, An X, Wang FH, Wang ZQ, Xu RH, Shao JY. EGFR fluorescence in situ hybridization pattern of chromosome 7 disomy predicts resistance to cetuximab in KRAS wild-type metastatic colorectal cancer patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 382-90. PMID 20884623 DOI: 10.1158/1078-0432.CCR-10-0208 |
0.364 |
|
Show low-probability matches. |